JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldberg, I. J.
Right arrow Articles by Pillarisetti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldberg, I. J.
Right arrow Articles by Pillarisetti, S.

J Biol Chem, Vol. 273, Issue 52, 35355-35361, December 25, 1998

The NH2-terminal Region of Apolipoprotein B Is Sufficient for Lipoprotein Association with Glycosaminoglycans

Ira J. GoldbergDagger , William D. Wagner, Ling PangDagger , Latha PakaDagger , Linda K. Curtissparallel , Jeanine A. DeLozier, Gregory S. Shelness, C. S. H. Young**, and Sivaram PillarisettiDagger

From the Departments of Dagger  Medicine and ** Microbiology, Columbia University College of Physicians & Surgeons, New York, New York 10032, the  Department of Pathology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, and the parallel  Scripps Research Institute, La Jolla, California 92037

An initial event in atherosclerosis is the retention of lipoproteins within the intima of the vessel wall. The co-localization of apolipoprotein (apo) B and proteoglycans within lesions has suggested that retention is due to lipoprotein interaction with these highly electronegative glycoconjugates. Both apoB100- and apoB48-containing lipoproteins, i.e. low density lipoproteins (LDLs) and chylomicron remnants, are atherogenic. This suggests that retention is due to determinants in the initial 48% of apoB. To test this, the interaction of an apoB fragment (apoB17), and apoB48- and apoB100- containing lipoproteins with heparin, subendothelial matrix, and artery wall purified proteoglycans was studied. ApoB100-containing LDL from humans and human apoB transgenic mice and apoB48-containing LDLs from apoE knockout mice were used. Despite the lack of the carboxyl-terminal 52% of apoB, the apoB48-LDL bound to heparin-affinity gel as well as did apoB100-LDL. An NH2-terminal fragment containing 17% of full-length apoB was made using a recombinant adenovirus; apoB17 bound to heparin as well as did LDL. Monoclonal antibodies against the NH2-terminal region of apoB decreased apoB100 LDL binding to heparin, whereas antibodies against the LDL receptor-binding region did not alter LDL-heparin interaction. The role of the NH2-terminal region of apoB in LDL interaction with matrix molecules was also assessed. Media containing apoB17 decreased LDL binding to subendothelial matrix by 42%. Moreover, removal of the apoB17 by immunoprecipitation abrogated the inhibitory effect of these media. Antibodies to the NH2-terminal region decreased LDL binding to matrix and dermatan sulfate proteoglycans. Purified apoB17 effectively competed for binding of LDL to artery derived decorin and to subendothelial matrix. Thus, despite the presence of multiple basic amino acids near the LDL receptor-binding domain of LDL, the NH2-terminal region of apoB is sufficient for the interaction of lipoproteins with glycoconjugates produced by endothelial and smooth muscle cells. The presence of a proteoglycan-binding site in the NH2-terminal region of apoB may explain why apoB48- and apoB100-containing lipoproteins are equally atherogenic.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
CirculationHome page
I. Tabas, K. J. Williams, and J. Boren
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Circulation, October 16, 2007; 116(16): 1832 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Y. Chang, C.-Y. Han, T. N. Wight, and A. Chait
Antioxidants Inhibit the Ability of Lysophosphatidylcholine to Regulate Proteoglycan Synthesis
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
P. E. Richardson, M. Manchekar, N. Dashti, M. K. Jones, A. Beigneux, S. G. Young, S. C. Harvey, and J. P. Segrest
Assembly of Lipoprotein Particles Containing Apolipoprotein-B: Structural Model for the Nascent Lipoprotein Particle
Biophys. J., April 1, 2005; 88(4): 2789 - 2800.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
A. Saito and H. Munakata
Factor H Is a Dermatan Sulfate-Binding Protein: Identification of a Dermatan Sulfate-Mediated Protease That Cleaves Factor H
J. Biochem., February 1, 2005; 137(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. F. Khalil, W. D. Wagner, and I. J. Goldberg
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. K. Vikramadithyan, Y. Kako, G. Chen, Y. Hu, E. Arikawa-Hirasawa, Y. Yamada, and I. J. Goldberg
Atherosclerosis in perlecan heterozygous mice
J. Lipid Res., October 1, 2004; 45(10): 1806 - 1812.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S.-J. Lee, S. Kadambi, C. David, A. D. Cooper, and S. Y. Choi
Association of hepatic lipase with proteoglycans stimulates the production of proteoglycans in vivo and in vitro
J. Lipid Res., July 1, 2004; 45(7): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Chen, R. L. Fitzgerald, J. E. Saffitz, C. F. Semenkovich, and G. Schonfeld
Amino Terminal 38.9% of Apolipoprotein B-100 Is Sufficient to Support Cholesterol-Rich Lipoprotein Production and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Ananyeva, A. Tjurmin, E. Saenko, and C. Haudenschild
Low Density Lipoproteins Interact With Acidic Fibroblast Growth Factor and Modify Its Function
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Flood, M. Gustafsson, P. E. Richardson, S. C. Harvey, J. P. Segrest, and J. Boren
Identification of the Proteoglycan Binding Site in Apolipoprotein B48
J. Biol. Chem., August 23, 2002; 277(35): 32228 - 32233.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. P. Segrest, M. K. Jones, H. De Loof, and N. Dashti
Structure of apolipoprotein B-100 in low density lipoproteins
J. Lipid Res., September 1, 2001; 42(9): 1346 - 1367.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. A. DeLozier, J. S. Parks, and G. S. Shelness
Vesicle-binding properties of wild-type and cysteine mutant forms of {{alpha}}1 domain of apolipoprotein B
J. Lipid Res., March 1, 2001; 42(3): 399 - 406.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
Z. Li, Y. Kako, L. Pang, M. W. Freeman, J. M. Glick, X. Wang, and I. J. Goldberg
Effects of overexpression of the amino-terminal fragment of apolipoprotein B on apolipoprotein B and lipoprotein production
J. Lipid Res., December 1, 2000; 41(12): 1912 - 1920.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. M. Hussain, J. C. Obunike, A. Shaheen, M. J. Hussain, G. S. Shelness, and I. J. Goldberg
High Affinity Binding between Lipoprotein Lipase and Lipoproteins Involves Multiple Ionic and Hydrophobic Interactions, Does Not Require Enzyme Activity, and Is Modulated by Glycosaminoglycans
J. Biol. Chem., September 15, 2000; 275(38): 29324 - 29330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Becker, R. S. McLeod, S. M. Marcovina, Z. Yao, and M. L. Koschinsky
Identification of a Critical Lysine Residue in Apolipoprotein B-100 That Mediates Noncovalent Interaction with Apolipoprotein(a)
J. Biol. Chem., September 21, 2001; 276(39): 36155 - 36162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.